Dr. Greg Shay is a pediatric pulmonologist, a children's lung specialist, with the NGO MedGlobal who has just returned from a ...
DPA International on MSN16m
Science journal: HIV protection is 2024 research breakthroughThe development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir – a promising new injectable drug that prevents HIV infection. The award also recognizes related work surrounding ...
At the HIV Analyst & Investor Event on Tuesday, Gilead Sciences Inc. (NASDAQ:GILD) revealed that it is developing a ...
Musk has argued in favor of regulating AI. But venture capitalists like Andreessen, who founded Andreessen Horowitz, a VC ...
A post on Facebook claims that a new cure for Acquired immunodeficiency syndrome (AIDS) has been discovered and will cost $40 ...
Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...
The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback